NCT04342130View on ClinicalTrials.gov

Brain Effects of Opiate Agonist and Antagonist

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 27, 2018

Primary Completion Date

April 16, 2019

Study Completion Date

April 16, 2019

Conditions
Chronic Low-back Pain
Interventions
DRUG

Morphine

30 mg oral tablet

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
lead

University of Rochester

OTHER

NCT04342130 - Brain Effects of Opiate Agonist and Antagonist | Biotech Hunter | Biotech Hunter